DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
Quarterly Data
Decomposing ROE involves expressing net income divided by shareholders’ equity as the product of component ratios.
Two-Component Disaggregation of ROE
Medtronic PLC, decomposition of ROE (quarterly data)
|
|
|
|
|
|
|
ROE |
= |
ROA |
× |
Financial Leverage |
Jan 24, 2025 |
8.63% |
= |
4.73% |
× |
1.82 |
Oct 25, 2024 |
8.84% |
= |
4.76% |
× |
1.86 |
Jul 26, 2024 |
8.19% |
= |
4.38% |
× |
1.87 |
Apr 26, 2024 |
7.32% |
= |
4.09% |
× |
1.79 |
Jan 26, 2024 |
8.11% |
= |
4.63% |
× |
1.75 |
Oct 27, 2023 |
7.97% |
= |
4.55% |
× |
1.75 |
Jul 28, 2023 |
7.07% |
= |
3.99% |
× |
1.77 |
Apr 28, 2023 |
7.30% |
= |
4.13% |
× |
1.77 |
Jan 27, 2023 |
7.90% |
= |
4.32% |
× |
1.83 |
Oct 28, 2022 |
8.33% |
= |
4.63% |
× |
1.80 |
Jul 29, 2022 |
9.88% |
= |
5.79% |
× |
1.71 |
Apr 29, 2022 |
9.59% |
= |
5.54% |
× |
1.73 |
Jan 28, 2022 |
9.35% |
= |
5.35% |
× |
1.75 |
Oct 29, 2021 |
9.05% |
= |
5.13% |
× |
1.76 |
Jul 30, 2021 |
7.54% |
= |
4.23% |
× |
1.78 |
Apr 30, 2021 |
7.01% |
= |
3.87% |
× |
1.81 |
Jan 29, 2021 |
5.70% |
= |
2.97% |
× |
1.92 |
Oct 30, 2020 |
7.05% |
= |
3.69% |
× |
1.91 |
Jul 31, 2020 |
8.77% |
= |
4.70% |
× |
1.87 |
Apr 24, 2020 |
9.44% |
= |
5.28% |
× |
1.79 |
Jan 24, 2020 |
10.26% |
= |
5.73% |
× |
1.79 |
Oct 25, 2019 |
9.23% |
= |
5.13% |
× |
1.80 |
Jul 26, 2019 |
8.78% |
= |
4.84% |
× |
1.81 |
Apr 26, 2019 |
9.25% |
= |
5.16% |
× |
1.79 |
Jan 25, 2019 |
— |
= |
— |
× |
1.78 |
Oct 26, 2018 |
— |
= |
— |
× |
1.78 |
Jul 27, 2018 |
— |
= |
— |
× |
1.79 |
Based on:
10-Q (reporting date: 2025-01-24),
10-Q (reporting date: 2024-10-25),
10-Q (reporting date: 2024-07-26),
10-K (reporting date: 2024-04-26),
10-Q (reporting date: 2024-01-26),
10-Q (reporting date: 2023-10-27),
10-Q (reporting date: 2023-07-28),
10-K (reporting date: 2023-04-28),
10-Q (reporting date: 2023-01-27),
10-Q (reporting date: 2022-10-28),
10-Q (reporting date: 2022-07-29),
10-K (reporting date: 2022-04-29),
10-Q (reporting date: 2022-01-28),
10-Q (reporting date: 2021-10-29),
10-Q (reporting date: 2021-07-30),
10-K (reporting date: 2021-04-30),
10-Q (reporting date: 2021-01-29),
10-Q (reporting date: 2020-10-30),
10-Q (reporting date: 2020-07-31),
10-K (reporting date: 2020-04-24),
10-Q (reporting date: 2020-01-24),
10-Q (reporting date: 2019-10-25),
10-Q (reporting date: 2019-07-26),
10-K (reporting date: 2019-04-26),
10-Q (reporting date: 2019-01-25),
10-Q (reporting date: 2018-10-26),
10-Q (reporting date: 2018-07-27).
The primary reason for the decrease in return on equity ratio (ROE) over Q3 2025 is the decrease in financial leverage ratio.
Three-Component Disaggregation of ROE
Medtronic PLC, decomposition of ROE (quarterly data)
|
|
|
|
|
|
|
|
|
ROE |
= |
Net Profit Margin |
× |
Asset Turnover |
× |
Financial Leverage |
Jan 24, 2025 |
8.63% |
= |
12.83% |
× |
0.37 |
× |
1.82 |
Oct 25, 2024 |
8.84% |
= |
13.00% |
× |
0.37 |
× |
1.86 |
Jul 26, 2024 |
8.19% |
= |
12.05% |
× |
0.36 |
× |
1.87 |
Apr 26, 2024 |
7.32% |
= |
11.36% |
× |
0.36 |
× |
1.79 |
Jan 26, 2024 |
8.11% |
= |
13.00% |
× |
0.36 |
× |
1.75 |
Oct 27, 2023 |
7.97% |
= |
12.84% |
× |
0.35 |
× |
1.75 |
Jul 28, 2023 |
7.07% |
= |
11.47% |
× |
0.35 |
× |
1.77 |
Apr 28, 2023 |
7.30% |
= |
12.03% |
× |
0.34 |
× |
1.77 |
Jan 27, 2023 |
7.90% |
= |
13.20% |
× |
0.33 |
× |
1.83 |
Oct 28, 2022 |
8.33% |
= |
14.03% |
× |
0.33 |
× |
1.80 |
Jul 29, 2022 |
9.88% |
= |
16.75% |
× |
0.35 |
× |
1.71 |
Apr 29, 2022 |
9.59% |
= |
15.90% |
× |
0.35 |
× |
1.73 |
Jan 28, 2022 |
9.35% |
= |
15.46% |
× |
0.35 |
× |
1.75 |
Oct 29, 2021 |
9.05% |
= |
14.79% |
× |
0.35 |
× |
1.76 |
Jul 30, 2021 |
7.54% |
= |
12.29% |
× |
0.34 |
× |
1.78 |
Apr 30, 2021 |
7.01% |
= |
11.97% |
× |
0.32 |
× |
1.81 |
Jan 29, 2021 |
5.70% |
= |
10.36% |
× |
0.29 |
× |
1.92 |
Oct 30, 2020 |
7.05% |
= |
12.69% |
× |
0.29 |
× |
1.91 |
Jul 31, 2020 |
8.77% |
= |
15.80% |
× |
0.30 |
× |
1.87 |
Apr 24, 2020 |
9.44% |
= |
16.56% |
× |
0.32 |
× |
1.79 |
Jan 24, 2020 |
10.26% |
= |
17.11% |
× |
0.33 |
× |
1.79 |
Oct 25, 2019 |
9.23% |
= |
15.11% |
× |
0.34 |
× |
1.80 |
Jul 26, 2019 |
8.78% |
= |
14.41% |
× |
0.34 |
× |
1.81 |
Apr 26, 2019 |
9.25% |
= |
15.16% |
× |
0.34 |
× |
1.79 |
Jan 25, 2019 |
— |
= |
— |
× |
— |
× |
1.78 |
Oct 26, 2018 |
— |
= |
— |
× |
— |
× |
1.78 |
Jul 27, 2018 |
— |
= |
— |
× |
— |
× |
1.79 |
Based on:
10-Q (reporting date: 2025-01-24),
10-Q (reporting date: 2024-10-25),
10-Q (reporting date: 2024-07-26),
10-K (reporting date: 2024-04-26),
10-Q (reporting date: 2024-01-26),
10-Q (reporting date: 2023-10-27),
10-Q (reporting date: 2023-07-28),
10-K (reporting date: 2023-04-28),
10-Q (reporting date: 2023-01-27),
10-Q (reporting date: 2022-10-28),
10-Q (reporting date: 2022-07-29),
10-K (reporting date: 2022-04-29),
10-Q (reporting date: 2022-01-28),
10-Q (reporting date: 2021-10-29),
10-Q (reporting date: 2021-07-30),
10-K (reporting date: 2021-04-30),
10-Q (reporting date: 2021-01-29),
10-Q (reporting date: 2020-10-30),
10-Q (reporting date: 2020-07-31),
10-K (reporting date: 2020-04-24),
10-Q (reporting date: 2020-01-24),
10-Q (reporting date: 2019-10-25),
10-Q (reporting date: 2019-07-26),
10-K (reporting date: 2019-04-26),
10-Q (reporting date: 2019-01-25),
10-Q (reporting date: 2018-10-26),
10-Q (reporting date: 2018-07-27).
The primary reason for the decrease in return on equity ratio (ROE) over Q3 2025 is the decrease in financial leverage ratio.
Five-Component Disaggregation of ROE
Medtronic PLC, decomposition of ROE (quarterly data)
|
|
|
|
|
|
|
|
|
|
|
|
|
ROE |
= |
Tax Burden |
× |
Interest Burden |
× |
EBIT Margin |
× |
Asset Turnover |
× |
Financial Leverage |
Jan 24, 2025 |
8.63% |
= |
0.82 |
× |
0.87 |
× |
17.93% |
× |
0.37 |
× |
1.82 |
Oct 25, 2024 |
8.84% |
= |
0.84 |
× |
0.87 |
× |
17.84% |
× |
0.37 |
× |
1.86 |
Jul 26, 2024 |
8.19% |
= |
0.80 |
× |
0.87 |
× |
17.24% |
× |
0.36 |
× |
1.87 |
Apr 26, 2024 |
7.32% |
= |
0.76 |
× |
0.87 |
× |
17.08% |
× |
0.36 |
× |
1.79 |
Jan 26, 2024 |
8.11% |
= |
0.76 |
× |
0.89 |
× |
19.19% |
× |
0.36 |
× |
1.75 |
Oct 27, 2023 |
7.97% |
= |
0.76 |
× |
0.89 |
× |
19.06% |
× |
0.35 |
× |
1.75 |
Jul 28, 2023 |
7.07% |
= |
0.66 |
× |
0.90 |
× |
19.35% |
× |
0.35 |
× |
1.77 |
Apr 28, 2023 |
7.30% |
= |
0.70 |
× |
0.89 |
× |
19.13% |
× |
0.34 |
× |
1.77 |
Jan 27, 2023 |
7.90% |
= |
0.75 |
× |
0.90 |
× |
19.44% |
× |
0.33 |
× |
1.83 |
Oct 28, 2022 |
8.33% |
= |
0.77 |
× |
0.91 |
× |
20.03% |
× |
0.33 |
× |
1.80 |
Jul 29, 2022 |
9.88% |
= |
0.91 |
× |
0.91 |
× |
20.24% |
× |
0.35 |
× |
1.71 |
Apr 29, 2022 |
9.59% |
= |
0.92 |
× |
0.91 |
× |
19.08% |
× |
0.35 |
× |
1.73 |
Jan 28, 2022 |
9.35% |
= |
0.90 |
× |
0.91 |
× |
18.91% |
× |
0.35 |
× |
1.75 |
Oct 29, 2021 |
9.05% |
= |
0.93 |
× |
0.90 |
× |
17.74% |
× |
0.35 |
× |
1.76 |
Jul 30, 2021 |
7.54% |
= |
0.94 |
× |
0.82 |
× |
15.85% |
× |
0.34 |
× |
1.78 |
Apr 30, 2021 |
7.01% |
= |
0.93 |
× |
0.81 |
× |
15.92% |
× |
0.32 |
× |
1.81 |
Jan 29, 2021 |
5.70% |
= |
1.15 |
× |
0.73 |
× |
12.42% |
× |
0.29 |
× |
1.92 |
Oct 30, 2020 |
7.05% |
= |
1.23 |
× |
0.75 |
× |
13.80% |
× |
0.29 |
× |
1.91 |
Jul 31, 2020 |
8.77% |
= |
1.21 |
× |
0.85 |
× |
15.43% |
× |
0.30 |
× |
1.87 |
Apr 24, 2020 |
9.44% |
= |
1.19 |
× |
0.79 |
× |
17.74% |
× |
0.32 |
× |
1.79 |
Jan 24, 2020 |
10.26% |
= |
1.04 |
× |
0.76 |
× |
21.75% |
× |
0.33 |
× |
1.79 |
Oct 25, 2019 |
9.23% |
= |
0.95 |
× |
0.74 |
× |
21.48% |
× |
0.34 |
× |
1.80 |
Jul 26, 2019 |
8.78% |
= |
0.89 |
× |
0.73 |
× |
22.09% |
× |
0.34 |
× |
1.81 |
Apr 26, 2019 |
9.25% |
= |
0.89 |
× |
0.78 |
× |
21.67% |
× |
0.34 |
× |
1.79 |
Jan 25, 2019 |
— |
= |
— |
× |
— |
× |
— |
× |
— |
× |
1.78 |
Oct 26, 2018 |
— |
= |
— |
× |
— |
× |
— |
× |
— |
× |
1.78 |
Jul 27, 2018 |
— |
= |
— |
× |
— |
× |
— |
× |
— |
× |
1.79 |
Based on:
10-Q (reporting date: 2025-01-24),
10-Q (reporting date: 2024-10-25),
10-Q (reporting date: 2024-07-26),
10-K (reporting date: 2024-04-26),
10-Q (reporting date: 2024-01-26),
10-Q (reporting date: 2023-10-27),
10-Q (reporting date: 2023-07-28),
10-K (reporting date: 2023-04-28),
10-Q (reporting date: 2023-01-27),
10-Q (reporting date: 2022-10-28),
10-Q (reporting date: 2022-07-29),
10-K (reporting date: 2022-04-29),
10-Q (reporting date: 2022-01-28),
10-Q (reporting date: 2021-10-29),
10-Q (reporting date: 2021-07-30),
10-K (reporting date: 2021-04-30),
10-Q (reporting date: 2021-01-29),
10-Q (reporting date: 2020-10-30),
10-Q (reporting date: 2020-07-31),
10-K (reporting date: 2020-04-24),
10-Q (reporting date: 2020-01-24),
10-Q (reporting date: 2019-10-25),
10-Q (reporting date: 2019-07-26),
10-K (reporting date: 2019-04-26),
10-Q (reporting date: 2019-01-25),
10-Q (reporting date: 2018-10-26),
10-Q (reporting date: 2018-07-27).
The primary reason for the decrease in return on equity ratio (ROE) over Q3 2025 is the decrease in effect of taxes measured by tax burden ratio.
Two-Component Disaggregation of ROA
Medtronic PLC, decomposition of ROA (quarterly data)
|
|
|
|
|
|
|
ROA |
= |
Net Profit Margin |
× |
Asset Turnover |
Jan 24, 2025 |
4.73% |
= |
12.83% |
× |
0.37 |
Oct 25, 2024 |
4.76% |
= |
13.00% |
× |
0.37 |
Jul 26, 2024 |
4.38% |
= |
12.05% |
× |
0.36 |
Apr 26, 2024 |
4.09% |
= |
11.36% |
× |
0.36 |
Jan 26, 2024 |
4.63% |
= |
13.00% |
× |
0.36 |
Oct 27, 2023 |
4.55% |
= |
12.84% |
× |
0.35 |
Jul 28, 2023 |
3.99% |
= |
11.47% |
× |
0.35 |
Apr 28, 2023 |
4.13% |
= |
12.03% |
× |
0.34 |
Jan 27, 2023 |
4.32% |
= |
13.20% |
× |
0.33 |
Oct 28, 2022 |
4.63% |
= |
14.03% |
× |
0.33 |
Jul 29, 2022 |
5.79% |
= |
16.75% |
× |
0.35 |
Apr 29, 2022 |
5.54% |
= |
15.90% |
× |
0.35 |
Jan 28, 2022 |
5.35% |
= |
15.46% |
× |
0.35 |
Oct 29, 2021 |
5.13% |
= |
14.79% |
× |
0.35 |
Jul 30, 2021 |
4.23% |
= |
12.29% |
× |
0.34 |
Apr 30, 2021 |
3.87% |
= |
11.97% |
× |
0.32 |
Jan 29, 2021 |
2.97% |
= |
10.36% |
× |
0.29 |
Oct 30, 2020 |
3.69% |
= |
12.69% |
× |
0.29 |
Jul 31, 2020 |
4.70% |
= |
15.80% |
× |
0.30 |
Apr 24, 2020 |
5.28% |
= |
16.56% |
× |
0.32 |
Jan 24, 2020 |
5.73% |
= |
17.11% |
× |
0.33 |
Oct 25, 2019 |
5.13% |
= |
15.11% |
× |
0.34 |
Jul 26, 2019 |
4.84% |
= |
14.41% |
× |
0.34 |
Apr 26, 2019 |
5.16% |
= |
15.16% |
× |
0.34 |
Jan 25, 2019 |
— |
= |
— |
× |
— |
Oct 26, 2018 |
— |
= |
— |
× |
— |
Jul 27, 2018 |
— |
= |
— |
× |
— |
Based on:
10-Q (reporting date: 2025-01-24),
10-Q (reporting date: 2024-10-25),
10-Q (reporting date: 2024-07-26),
10-K (reporting date: 2024-04-26),
10-Q (reporting date: 2024-01-26),
10-Q (reporting date: 2023-10-27),
10-Q (reporting date: 2023-07-28),
10-K (reporting date: 2023-04-28),
10-Q (reporting date: 2023-01-27),
10-Q (reporting date: 2022-10-28),
10-Q (reporting date: 2022-07-29),
10-K (reporting date: 2022-04-29),
10-Q (reporting date: 2022-01-28),
10-Q (reporting date: 2021-10-29),
10-Q (reporting date: 2021-07-30),
10-K (reporting date: 2021-04-30),
10-Q (reporting date: 2021-01-29),
10-Q (reporting date: 2020-10-30),
10-Q (reporting date: 2020-07-31),
10-K (reporting date: 2020-04-24),
10-Q (reporting date: 2020-01-24),
10-Q (reporting date: 2019-10-25),
10-Q (reporting date: 2019-07-26),
10-K (reporting date: 2019-04-26),
10-Q (reporting date: 2019-01-25),
10-Q (reporting date: 2018-10-26),
10-Q (reporting date: 2018-07-27).
The primary reason for the decrease in return on assets ratio (ROA) over Q3 2025 is the decrease in profitability measured by net profit margin ratio.
Four-Component Disaggregation of ROA
Medtronic PLC, decomposition of ROA (quarterly data)
|
|
|
|
|
|
|
|
|
|
|
ROA |
= |
Tax Burden |
× |
Interest Burden |
× |
EBIT Margin |
× |
Asset Turnover |
Jan 24, 2025 |
4.73% |
= |
0.82 |
× |
0.87 |
× |
17.93% |
× |
0.37 |
Oct 25, 2024 |
4.76% |
= |
0.84 |
× |
0.87 |
× |
17.84% |
× |
0.37 |
Jul 26, 2024 |
4.38% |
= |
0.80 |
× |
0.87 |
× |
17.24% |
× |
0.36 |
Apr 26, 2024 |
4.09% |
= |
0.76 |
× |
0.87 |
× |
17.08% |
× |
0.36 |
Jan 26, 2024 |
4.63% |
= |
0.76 |
× |
0.89 |
× |
19.19% |
× |
0.36 |
Oct 27, 2023 |
4.55% |
= |
0.76 |
× |
0.89 |
× |
19.06% |
× |
0.35 |
Jul 28, 2023 |
3.99% |
= |
0.66 |
× |
0.90 |
× |
19.35% |
× |
0.35 |
Apr 28, 2023 |
4.13% |
= |
0.70 |
× |
0.89 |
× |
19.13% |
× |
0.34 |
Jan 27, 2023 |
4.32% |
= |
0.75 |
× |
0.90 |
× |
19.44% |
× |
0.33 |
Oct 28, 2022 |
4.63% |
= |
0.77 |
× |
0.91 |
× |
20.03% |
× |
0.33 |
Jul 29, 2022 |
5.79% |
= |
0.91 |
× |
0.91 |
× |
20.24% |
× |
0.35 |
Apr 29, 2022 |
5.54% |
= |
0.92 |
× |
0.91 |
× |
19.08% |
× |
0.35 |
Jan 28, 2022 |
5.35% |
= |
0.90 |
× |
0.91 |
× |
18.91% |
× |
0.35 |
Oct 29, 2021 |
5.13% |
= |
0.93 |
× |
0.90 |
× |
17.74% |
× |
0.35 |
Jul 30, 2021 |
4.23% |
= |
0.94 |
× |
0.82 |
× |
15.85% |
× |
0.34 |
Apr 30, 2021 |
3.87% |
= |
0.93 |
× |
0.81 |
× |
15.92% |
× |
0.32 |
Jan 29, 2021 |
2.97% |
= |
1.15 |
× |
0.73 |
× |
12.42% |
× |
0.29 |
Oct 30, 2020 |
3.69% |
= |
1.23 |
× |
0.75 |
× |
13.80% |
× |
0.29 |
Jul 31, 2020 |
4.70% |
= |
1.21 |
× |
0.85 |
× |
15.43% |
× |
0.30 |
Apr 24, 2020 |
5.28% |
= |
1.19 |
× |
0.79 |
× |
17.74% |
× |
0.32 |
Jan 24, 2020 |
5.73% |
= |
1.04 |
× |
0.76 |
× |
21.75% |
× |
0.33 |
Oct 25, 2019 |
5.13% |
= |
0.95 |
× |
0.74 |
× |
21.48% |
× |
0.34 |
Jul 26, 2019 |
4.84% |
= |
0.89 |
× |
0.73 |
× |
22.09% |
× |
0.34 |
Apr 26, 2019 |
5.16% |
= |
0.89 |
× |
0.78 |
× |
21.67% |
× |
0.34 |
Jan 25, 2019 |
— |
= |
— |
× |
— |
× |
— |
× |
— |
Oct 26, 2018 |
— |
= |
— |
× |
— |
× |
— |
× |
— |
Jul 27, 2018 |
— |
= |
— |
× |
— |
× |
— |
× |
— |
Based on:
10-Q (reporting date: 2025-01-24),
10-Q (reporting date: 2024-10-25),
10-Q (reporting date: 2024-07-26),
10-K (reporting date: 2024-04-26),
10-Q (reporting date: 2024-01-26),
10-Q (reporting date: 2023-10-27),
10-Q (reporting date: 2023-07-28),
10-K (reporting date: 2023-04-28),
10-Q (reporting date: 2023-01-27),
10-Q (reporting date: 2022-10-28),
10-Q (reporting date: 2022-07-29),
10-K (reporting date: 2022-04-29),
10-Q (reporting date: 2022-01-28),
10-Q (reporting date: 2021-10-29),
10-Q (reporting date: 2021-07-30),
10-K (reporting date: 2021-04-30),
10-Q (reporting date: 2021-01-29),
10-Q (reporting date: 2020-10-30),
10-Q (reporting date: 2020-07-31),
10-K (reporting date: 2020-04-24),
10-Q (reporting date: 2020-01-24),
10-Q (reporting date: 2019-10-25),
10-Q (reporting date: 2019-07-26),
10-K (reporting date: 2019-04-26),
10-Q (reporting date: 2019-01-25),
10-Q (reporting date: 2018-10-26),
10-Q (reporting date: 2018-07-27).
The primary reason for the decrease in return on assets ratio (ROA) over Q3 2025 is the decrease in effect of taxes measured by tax burden ratio.
Disaggregation of Net Profit Margin
Medtronic PLC, decomposition of net profit margin ratio (quarterly data)
|
|
|
|
|
|
|
|
|
Net Profit Margin |
= |
Tax Burden |
× |
Interest Burden |
× |
EBIT Margin |
Jan 24, 2025 |
12.83% |
= |
0.82 |
× |
0.87 |
× |
17.93% |
Oct 25, 2024 |
13.00% |
= |
0.84 |
× |
0.87 |
× |
17.84% |
Jul 26, 2024 |
12.05% |
= |
0.80 |
× |
0.87 |
× |
17.24% |
Apr 26, 2024 |
11.36% |
= |
0.76 |
× |
0.87 |
× |
17.08% |
Jan 26, 2024 |
13.00% |
= |
0.76 |
× |
0.89 |
× |
19.19% |
Oct 27, 2023 |
12.84% |
= |
0.76 |
× |
0.89 |
× |
19.06% |
Jul 28, 2023 |
11.47% |
= |
0.66 |
× |
0.90 |
× |
19.35% |
Apr 28, 2023 |
12.03% |
= |
0.70 |
× |
0.89 |
× |
19.13% |
Jan 27, 2023 |
13.20% |
= |
0.75 |
× |
0.90 |
× |
19.44% |
Oct 28, 2022 |
14.03% |
= |
0.77 |
× |
0.91 |
× |
20.03% |
Jul 29, 2022 |
16.75% |
= |
0.91 |
× |
0.91 |
× |
20.24% |
Apr 29, 2022 |
15.90% |
= |
0.92 |
× |
0.91 |
× |
19.08% |
Jan 28, 2022 |
15.46% |
= |
0.90 |
× |
0.91 |
× |
18.91% |
Oct 29, 2021 |
14.79% |
= |
0.93 |
× |
0.90 |
× |
17.74% |
Jul 30, 2021 |
12.29% |
= |
0.94 |
× |
0.82 |
× |
15.85% |
Apr 30, 2021 |
11.97% |
= |
0.93 |
× |
0.81 |
× |
15.92% |
Jan 29, 2021 |
10.36% |
= |
1.15 |
× |
0.73 |
× |
12.42% |
Oct 30, 2020 |
12.69% |
= |
1.23 |
× |
0.75 |
× |
13.80% |
Jul 31, 2020 |
15.80% |
= |
1.21 |
× |
0.85 |
× |
15.43% |
Apr 24, 2020 |
16.56% |
= |
1.19 |
× |
0.79 |
× |
17.74% |
Jan 24, 2020 |
17.11% |
= |
1.04 |
× |
0.76 |
× |
21.75% |
Oct 25, 2019 |
15.11% |
= |
0.95 |
× |
0.74 |
× |
21.48% |
Jul 26, 2019 |
14.41% |
= |
0.89 |
× |
0.73 |
× |
22.09% |
Apr 26, 2019 |
15.16% |
= |
0.89 |
× |
0.78 |
× |
21.67% |
Jan 25, 2019 |
— |
= |
— |
× |
— |
× |
— |
Oct 26, 2018 |
— |
= |
— |
× |
— |
× |
— |
Jul 27, 2018 |
— |
= |
— |
× |
— |
× |
— |
Based on:
10-Q (reporting date: 2025-01-24),
10-Q (reporting date: 2024-10-25),
10-Q (reporting date: 2024-07-26),
10-K (reporting date: 2024-04-26),
10-Q (reporting date: 2024-01-26),
10-Q (reporting date: 2023-10-27),
10-Q (reporting date: 2023-07-28),
10-K (reporting date: 2023-04-28),
10-Q (reporting date: 2023-01-27),
10-Q (reporting date: 2022-10-28),
10-Q (reporting date: 2022-07-29),
10-K (reporting date: 2022-04-29),
10-Q (reporting date: 2022-01-28),
10-Q (reporting date: 2021-10-29),
10-Q (reporting date: 2021-07-30),
10-K (reporting date: 2021-04-30),
10-Q (reporting date: 2021-01-29),
10-Q (reporting date: 2020-10-30),
10-Q (reporting date: 2020-07-31),
10-K (reporting date: 2020-04-24),
10-Q (reporting date: 2020-01-24),
10-Q (reporting date: 2019-10-25),
10-Q (reporting date: 2019-07-26),
10-K (reporting date: 2019-04-26),
10-Q (reporting date: 2019-01-25),
10-Q (reporting date: 2018-10-26),
10-Q (reporting date: 2018-07-27).
The primary reason for the decrease in net profit margin ratio over Q3 2025 is the decrease in effect of taxes measured by tax burden ratio.